Insider Transactions in Q2 2025 at Myomo, Inc. (MYO)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 11
2025
|
Harry Kovelman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
62,938
+29.06%
|
-
|
|
Jun 11
2025
|
Micah Mitchell Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
59,440
+22.94%
|
-
|
|
Jun 11
2025
|
David A Henry Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
76,398
+14.47%
|
-
|
|
Jun 11
2025
|
Paul R Gudonis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
157,342
+11.52%
|
-
|
|
Jun 11
2025
|
Thomas F Kirk |
BUY
Grant, award, or other acquisition
|
Direct |
29,720
+7.35%
|
-
|
|
Jun 11
2025
|
Thomas Aloysius Crowley Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
29,720
+29.29%
|
-
|
|
Jun 11
2025
|
Milton Mayo Morris |
BUY
Grant, award, or other acquisition
|
Direct |
29,720
+17.04%
|
-
|
|
Jun 11
2025
|
Heather C Getz |
BUY
Grant, award, or other acquisition
|
Direct |
29,720
+41.58%
|
-
|
|
Jun 06
2025
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,743
-5.95%
|
$11,486
$2.97 P/Share
|
|
Jun 06
2025
|
David A Henry Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,373
-2.18%
|
$16,746
$2.97 P/Share
|
|
May 15
2025
|
Thomas F Kirk |
BUY
Open market or private purchase
|
Direct |
36,824
+9.65%
|
$110,472
$3.25 P/Share
|
|
May 15
2025
|
Paul R Gudonis Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
30,000
+2.77%
|
$90,000
$3.22 P/Share
|
|
May 14
2025
|
Thomas F Kirk |
BUY
Open market or private purchase
|
Direct |
1,943
+0.63%
|
$5,829
$3.25 P/Share
|
|
May 12
2025
|
Thomas F Kirk |
BUY
Open market or private purchase
|
Direct |
50,000
+14.05%
|
$150,000
$3.35 P/Share
|